| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 305,05 | 307,90 | 09:45 | |
| 305,15 | 307,90 | 09:45 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 308,25 | 2 | |||
| 308,10 | 27 | |||
| 307,85 | 68 | |||
| 307,80 | 4 | |||
| 307,75 | 4 | |||
| 307,70 | 34 | |||
| 307,45 | 1 | |||
| 306,80 | 25 | |||
| 306,75 | 25 | |||
| 306,70 | 33 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/amg.htm [/URL] | ||||
| 36 | 303,60 | |||
| 25 | 303,55 | |||
| 25 | 303,50 | |||
| 25 | 302,70 | |||
| 4 | 302,45 | |||
| 74 | 302,40 | |||
| 2 | 302,30 | |||
| 61 | 302,20 | |||
| 13 | 301,95 | |||
| 34 | 301,85 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 299 | 0,746 | 223 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 09:18:05 | 305,85 | 27 |
| 09:18:05 | 305,55 | 18 |
| 09:10:21 | 306,40 | 12 |
| 09:10:21 | 306,40 | 3 |
| 09:10:20 | 306,40 | 10 |
| Tagesumsatz Xetra | +0,45 +0,15 % | 88 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375 | 11 | Insider Monkey | ||
| AMGEN Aktie jetzt für 0€ handeln | |||||
| 20.03. | How Amgen Makes Money | 20 | Investopedia | ||
| 19.03. | Defensive Biotech-Wetten? Warum Amgen und AbbVie strukturell wachsen - kleiner Player Mesoblast im Fokus | Small- & Micro Cap Investment | |||
| 19.03. | AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock? | 5 | Zacks | ||
| 17.03. | Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position | 21 | Insider Monkey |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | ACCESS Newswire | - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome -- Dermata plans to launch its first DTC product, our Foundational... ► Artikel lesen | |
| Do | ViroGates A/S: ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues | GlobeNewswire (Europe) | Company Announcement no. 1/2026 (March 26, 2026 at 15:10:00 CET)
Inside information
BIRKERØD, DENMARK ViroGates A/S ("ViroGates" or "Company"), a medical technology company developing blood tests for... ► Artikel lesen | |
| 01:06 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen Announces FDA IND Clearance for Partner NEOK Bio's NEOK002 Targeting Solid Tumors | Business Wire | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.03.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 26.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.03.2026.ISIN NameCA2568277834 DOLLY... ► Artikel lesen | |
| Do | NurExone stellt Weichen für Wachstum und Sichtbarkeit | Small- & Micro Cap Investment |